Schedule
21. International EBHC Symposium 2026
Multilevel HTA. Coordinating affordability across health care
October 8-9, 2026 | Krakow + ONLINE
21. International EBHC Symposium 2026
Multilevel HTA
Coordinating affordability across health care
October 8-9, 2026 | Krakow + ONLINE
- Session 1: Crisis or paradigm shift in the concept of healthcare
- Session 2: Development of HTA in Europe
- Session 3: Equity, value, and need: multidimensional assessment of health interventions
- Session 4: HTA: from recommendations to implementation in clinical practice
- Session 5: Does the patient perspective change the final assessment of health technology in the HTA process?
- Session 6: Public health – is it still Evidence-Based?
Session 1. Crisis or paradigm shift in the concept of healthcare
Moderator: Maria Libura
9.00 –10.20
1 h 20 min.
Opening of the Symposium
10 min.
Magdalena Władysiuk
Prezes CEESTAHC // Poland
Tomasz Jan Prycel
Dyrektor Zarządzający
CEESTAHC // Poland
Discussion panel
Are the current health care problems a temporary crisis or do they indicate the exhaustion of the current paradigm of care organization?
70 min.
Maria Libura
Poland
Jakub Szulc
Poland
Maciej Miłkowski
Poland
Tomasz Imiela
Poland
Magdalena Władysiuk
Prezes CEESTAHC // Poland
Karina Jahnz-Różyk
Poland
Michał Zabdyr-Jamróz
Poland
Coffee-break // 20 min. top
15 min.
Ann Single
Australia
15 min.
Mateusz Oczkowski
Poland
Discussion panel
Will access to medicines improve in light of global pricing changes – Europe and the USA?
50 min.
Mateusz Oczkowski
Poland
Przemysław Rzodkiewicz
Poland
Magdalena Władysiuk
Prezes CEESTAHC // Poland
Maciej Miłkowski
Poland
Irena Rej
Poland
Maciej Niewada
Poland
Łukasz Andrzejczyk
Poland
Lunch // 50 minut top
20 min.
Paweł Potocki
Poland
20 min.
Rafał Jaworski
Poland
20 min.
Medical training: Pre-hospital First Aid card, Tactical Combat Casualty Care card (TCCC card) and Israeli trauma bandage
10 min.
Session 4. HTA: from recommendations to implementation in clinical practice
Moderator: Magdalena Władysiuk
9.00 –11.20
2 h 20 min.
Health Technology Assessment Agency – new clinical practice guidelines
20 min.
Przemysław Rzodkiewicz
Poland
Hospital-based HTA in the light of digital developments
20 min.
Magdalena Władysiuk
Prezes CEESTAHC // Poland
Discussion
20 min.
Coffee-break // 20 min. top
20 min.
Magdalena Władysiuk
Prezes CEESTAHC // Poland
Discussion panel
Does patient inclusion actually improve access to care?
20 min.
Lunch // 40 minut top
Integrating health and social care. Can local governments play a role as decision-makers?
15 min.
Tadeusz Jędrzejczyk
Poland
Oncoeducator – a cooperation program in the field of prevention at the local government level
15 min.
Bożena Cybulska
Poland
Diabetes and other metabolic diseases – success factors of local government health policy programs
20 min.
Tomasz Jan Prycel
Dyrektor Zarządzający
CEESTAHC // Poland
Discussion and conclusion of the Symposium
20 min.
Magdalena Władysiuk
Prezes CEESTAHC // Poland
Tomasz Jan Prycel
Dyrektor Zarządzający
CEESTAHC // Poland
| Day 1 | Thursday, October 8, 2026 9.00–15.40 |
||
| Session 1. Crisis or paradigm shift in the concept of healthcare 9.00–10.30 // 1 h 30 min. |
Invited speakers | Time [min.] |
| Opening of the Symposium | Magdalena Władysiuk, Tomasz Jan Prycel | 10 |
| Discussion panel: Are the current health care problems a temporary crisis or do they indicate the exhaustion of the current paradigm of care organization? Maria Libura, Barbara Więckowska, Jakub Szulc, Waldemar Malinowski, Sebastian Sikorski, Tomasz Imiela, Michał Zabdyr-Jamróz, Magdalena Władysiuk, Jan Oleszczuk-Zygmuntowski |
80 | |
| Coffee-Break // 10.30-10.50 // 20 min. top |
||
| Session 2. Development of HTA in Europe 10.50–12.20 // 1 h 30 min. |
Invited speakers | Time [min.] |
| Is clinical evaluation at the EU level sufficient to increase access to drug technologies? | Ann Single | 15 |
| Development of access to medicines in the light of legislative changes | Mateusz Oczkowski | 15 |
| Discussion panel: Will access to medicines improve in light of global pricing changes - Europe and the USA? Mateusz Oczkowski, Przemysław Rzodkiewicz, Magdalena Władysiuk, Maciej Miłkowski, Wiktor Janicki, Irena Rej, Karina Jahnz-Różyk, Maciej Niewada |
60 | |
| Lunch 12.20-13.20 // 60 min. top |
||
| Session 3. Equity, value, and need: multidimensional assessment of health interventions 13.20–15.20 // 2 h |
Invited speakers | Time [min.] |
| Health equity – is it possible to assess it in clinical practice? | Mary Fletcher-Louis | 20 |
| Inequality in cancer care in Poland | Bernard Waśko | 20 |
| From diagnostics to therapy – how FRα reflex testing can streamline the care pathway for patients with ovarian cancer | Paweł Potocki | 20 |
| Social and fiscal impact of HPV vaccination in Poland – return on investment as a result of broader access to vaccination | Rafał Jaworski | 20 |
| Comprehensive pulmonology care in Poland | Małgorzata Czajkowska-Malinowska | 20 |
| Key elements of women’s health in medicine | Agnieszka Tycińska | 20 |
| Discussion: Mateusz Oczkowski, Przemysław Rzodkiewicz, Mary Fletcher-Louis, Bernard Waśko, Rafał Jaworski, Małgorzata Czajkowska-Malinowska, Agnieszka Tycińska, Paweł Potocki |
20 | |
| Day 2 | Friday, October 9, 2026 9.00–16.20 |
||
| Session 4. HTA: from recommendations to implementation in clinical practice 9.00–11.40 // 2 h 40 min. |
Invited speakers | Time [min.] |
| Health Technology Assessment Agency – new clinical practice guidelines | Przemysław Rzodkiewicz | 20 |
| Assessment of medical technologies in the light of AI developments | Maciej Niewada | 20 |
| GRADE – assessment of uncertainty in clinical analysis | Małgorzata Bała | 20 |
| Data integration to advance real-world clinical practice | Marcin Waryszak | 20 |
| Digital technologies – shaping the future | Jennifer Goldsack | 20 |
| Developing RWE to inform HTA and optimize care: oncology as an example | Karen Facey | 20 |
| Hospital-based HTA in the light of digital developments | Magdalena Władysiuk | 20 |
| Discussion | 20 | |
| Coffee-Break // 11.40-12.00 // 20 min. top |
||
| Session 5. Public health – is it still Evidence-Based? 12.00–13.40 // 1 h 40 min. |
Invited speakers | Time [min.] |
| Population health assessment - what is needed for needs planning | Anna Smaga | 20 |
| Assessment of population needs - public health management systems | Paweł Grzesiowski | 15 |
| Integrating health and social care. Can local governments play a role as decision-makers? | Tadeusz Jędrzejczyk | 15 |
| Oncoeducator - a cooperation program in the field of prevention at the local government level | Paweł Zawadzki | 15 |
| Diabetes and other metabolic diseases - success factors of local government health policy programs | Tomasz Jan Prycel | 20 |
| Discussion | 15 | |
| Lunch 13.40-14.40 // 60 min. top |
||
| Session 6. Does the patient perspective change the final assessment of health technology in the HTA process? 14.40–16.20 // 1 h 40 min. |
Invited speakers | Time [min.] |
| Patient Perspectives within JCA | Valentina Strammiello | 20 |
| The patient perspective in the Polish HTA process | Małgorzata Skweres-Kuchta | 20 |
| Social care and health care - key elements of integration | Katarzyna Roszewska | 20 |
| Discussion panel: Does patient inclusion actually improve access to care? Maria Libura, Valentina Strammiello, Magdalena Kołodziej, Katarzyna Roszewska, Małgorzata Skweres-Kuchta |
20 | |
| Discussion and conclusion of the Symposium | 20 | |
English (UK) 
Polski